The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 03, 2025 for Aayush Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty Midcap 150 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Aayush Agrawal, through the Aayush Agrawal Trust, has disclosed creation of pledge on 6,45,000 shares (about 0.52% of total share capital) of Ajanta Pharma. The pledge was created on 26-Sep-2025 with Jio Finance Ltd for a new loan (4,55,000 shares) and on 30-Sep-2025 with Deutsche Investments India and HSBC InvestDirect for additional margin (1,90,000 shares combined). After these events, the total encumbered shares held by the Aayush Agrawal Trust stand at 65,80,002 shares (5.27%). The trust's overall holding in the company is 1,41,12,924 shares (11.30%).
Pledge creation by promoters is generally viewed cautiously as it signals new debt or margin obligations backed by shares. The pledged portion remains small (5.27% of the trust's holding), so immediate risk is limited, but investors should monitor for any further pledging or pledge invocation in future filings.